Tumor Markers

Tumor Markers is a class of biochemical substances, typically proteins or enzymes, whose abnormal concentration in the body fluids or tissues serves as an indicator of neoplastic activity, distinguishing it from other clinical biomarkers by its specific association with tumor presence, progression, or response to therapy.

35.2K

Publications

1.9M

Citations

153.4K

Authors

11.3K

Institutions

Publications per year

2017–2026

7.7K

Authors

153.4K

  1. EP
    Eleftherios P. Diamandis

    Mount Sinai Hospital, Canada

    120 publications · 9.3K citations

    56

    h-index

  2. KP
    Klaus Pantel

    Universität Hamburg, Germany

    87 publications · 8.2K citations

    50

    h-index

  3. RC
    Robert C. Bast

    The University of Texas MD Anderson Cancer Center, United States

    74 publications · 10.1K citations

    48

    h-index

  4. DL
    David L. Rimm

    Yale University, United States

    57 publications · 10.8K citations

    41

    h-index

  5. AS
    Andreas Scorilas

    National and Kapodistrian University of Athens, Greece

    71 publications · 4.5K citations

    41

    h-index

1–5 of 153.4K

Venues

  1. PubMed

    Repository · 4.5K publications · 241.7K citations

    191

    h-index

  2. Clinical Cancer Research

    479 publications · 57.6K citations

    127

    h-index

  3. International Journal of Cancer

    858 publications · 62.1K citations

    123

    h-index

  4. Cancer

    990 publications · 65.1K citations

    118

    h-index

  5. British Journal of Cancer

    BJC · 822 publications · 56.3K citations

    116

    h-index

1–5